Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

NCT00889486 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroparesis
Diabetes Mellitus

Interventions

DRUG: TZP-102
DRUG: Placebo

Sponsor

Tranzyme, Inc.